July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Amer Zeidan: Long Awaited Results of VERONA in Higher Risk MDS
Jun 17, 2025, 10:34

Amer Zeidan: Long Awaited Results of VERONA in Higher Risk MDS

Amer Zeidan, Chief of the Division of Hematologic Malignancies and Professor of Medicine at Yale University, shared a post on X:

“Long awaited results of VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk MDS. Subgroup analyses will be important.”

Read Full Article.

More posts featuring Amer Zeidan on OncoDaily.